>>> US Early premarket gappers

Early premarket gappers
Gapping up:
  • CLWT +49.3%, EXAS +15.8%, UCTT +15.5%, PIP +15.1%, SHOR +11.6%,TER +11%, UAA +9.1%, MKSI +7.5%, INTU +7.3%, NOK +7.1%, CRY +6.9%,ALSN +6.8%, WTW +6%, NOW +5.8%, GGG +5.7%, DRE +5.5%, TAL +5%,IVTY +4.7%, XLNX +4.4%, AUO +4.4%, PYPL +4.3%, SSW +4.3%, POT+4.2%, AXTI +4.1%, CMCSA +3.9%, KKR +3.9%, CRHM +3.8%, CRHM +3.8%,WPG +3.6%, ALXN +3.5%, YNDX +3.2%, HRB +2.8%, LYG +2.8%, BMY+2.8%, STM +2.8%, LKQ +2.7%, DVD +2.4%, MMLP +2.3%, CAVM +2.2%,STNG +2.2%, ROG +2.2%, CSGP +2.1%, RBS +2%, WLL +2%, F +1.9%, TSCO+1.8%, GG +1.8%, BWA +1.8%, KIM +1.5%, KIM +1.5%, CSCO +1.4%, GM+1.4%, DOW +1.4%, NTRI +1.3%, EXR +1.2%, RTN +1.1%, QEP +1%, CRR+1%, HAWK +0.8%, TOT +0.8%
Gapping down:
  • AMSC -35.7%, PACB -15.1%, MLNX -12.9%, JMP -8.4%, OPGN -8.3%, FFIV-7.9%, CMPR -7.2%, NTGR -5.6%, CTXS -5.5%, SFST -5%, BRKL -4.7%, BMS-4.4%, CTB -4.3%, EFX -4.1%, ETH -4%, ETH -4%, FTI -3.8%, AAL -3.7%,KN -3%, LUV -2.8%, DB -2.7%, ALKS -2.6%, BWLD -2.4%, AMGN -2.4%,CNHI -2.1%, KS -2%, ORLY -2%, BSX -1.8%, SERV -1.7%, EQIX -1.6%, X-1.5%, CS -1.5%, STAY -1.5%, NVCR -1.4%, TS -1.4%, AWH -1.2%, BBVA-1.2%, MT -1.1%, LLY -1.1%, MEOH -1%, AA -0.9%, LVS -0.9%, TYL -0.7%,MPWR -0.7%, FCFS -0.7%, DLB -0.5%, ORAN -0.5%

>>> Parker-Hannifin beats by $0.25, beats on revs; raises FY17 EPS above consens

Parker-Hannifin beats by $0.25, beats on revs; raises FY17 EPS above consensus
  • Reports Q3 (Mar) earnings of $2.11 per share, excluding non-recurring items, $0.25 better than the Capital IQ Consensus of $1.86; revenues rose 10.3% year/year to $3.12 bln vs the $3.03 bln Capital IQ Consensus.
    • Diversified Industrial Segment: North American second quarter sales decreased 3% to $1.1 billion, and operating income increased 20% to $184.0 million compared with $153.6 million in the same period a year ago. International second quarter sales increased 1% to $1.0 billion, while operating income increased 34% to $127.5 million compared with $95.4 million in the same period a year ago.
      Aerospace Systems Segment: Second quarter sales decreased 2% to $543.8 million, and operating income decreased 11% to $72.5 million compared with $81.8 million in the same period a year ago.
  • Co issues upside guidance for FY17, sees EPS of $7.70-8.00 ($7.05-7.55), excluding non-recurring items, vs. $7.53 Capital IQ Consensus Estimate.
  • "Our results reflect the hard work of Parker team members in better aligning our operational costs and execution of the new Win Strategy. We are increasing our organic growth forecast for the second half of the fiscal year from 2.3% to 3.3% at the midpoint in our new guidance. However, this increase in organic revenue is being offset by currency headwinds resulting in essentially flat full year reported annual sales growth versus fiscal 2016. We continue to deliver outstanding performance that positions us very well as we celebrate our 100th year as a company," said Chairman and CEO, Tom Williams.

>>> Under Armour up 10% following better than feared first quarter results (19.

Under Armour up 10% following better than feared first quarter results
  • Under Armour is up 10% after reporting Q1 results above guidance. Sales grew 6.7% vs. mid-single digit guidance while gross margin contracted 70 bps vs. -100 bps guidance. The company also reaffirmed its FY17 outlook. Investors were concerned about a weak Q1 amid the tough retail environment after the company missed fourth quarter estimates. 14% of the float is sold short. Peer/competitor NIKE (NKE) is indicated slightly higher.

>>> President Trump confirms on Twitter that NAFTA will be renegotiated; says wi

President Trump confirms on Twitter that NAFTA will be renegotiated; says will terminate NAFTA if US does not reach 'fair deal'
  • President Trump tweeted 'I received calls from the President of Mexico and the Prime Minister of Canada asking to renegotiate NAFTA rather than terminate. I agreed...subject to the fact that if we do not reach a fair deal for all, we will then terminate NAFTA. Relationships are good-deal very possible!"

Tweets :
1st Tweet : I received calls from the President of Mexico and the Prime Minister of Canada asking to renegotiate NAFTA rather than terminate. I agreed..

2st Tweet : ...subject to the fact that if we do not reach a fair deal for all, we will then terminate NAFTA. Relationships are good-deal very possible!

>>> CNH Industrial beats by $0.01, beats on revs; reaffirms FY17 guidance

CNH Industrial beats by $0.01, beats on revs; reaffirms FY17 guidance
  • Reports Q1 (Mar) earnings of $0.04 per share, excluding non-recurring items, $0.01 better than the Capital IQ Consensus of $0.03; revenues rose 5.8% year/year to $5.68 bln vs the $5.43 bln Capital IQ Consensus. Industrial Activities revenues up 6.1% (up 6.5% on a constant currency basis) driven by demand for agricultural equipment in the LATAM region, and in the Commercial Vehicles and Powertrain segments Operating profit of Industrial Activities at $219 million, an increase of 23%, at an operating margin of 4.1% driven by volume leverage in Agricultural Equipment and Powertrain.
  • Co reaffirms guidance for FY17, sees EPS of $0.39-0.41, excluding non-recurring items, vs. $0.38 Capital IQ Consensus Estimate; sees FY17 industrial revs of $23-24 bln, may not be comparable to $24.98 bln Capital IQ Consensus Estimate

>>> LendingTree misses by $0.06, beats on revs; guides Q2 revs above consensus;

LendingTree misses by $0.06, beats on revs; guides Q2 revs above consensus; guides FY17 revs above consensus, raises EBITDA guidance (125.75)
  • Reports Q1 (Mar) earnings of $0.85 per share, $0.06 worse than the Capital IQ Consensus of $0.91; revenues rose 39.9% year/year to $132.5 mln vs the $124.99 mln Capital IQ Consensus.
    • Total loan requests in the quarter of 4.8 million grew 49% compared to first quarter 2016
    • Record revenue from mortgage products of $62.9 million represents an increase of 14% over first quarter 2016 primarily driven by growth in purchase revenue, although refinance revenue also increased.
    • Record revenue from non-mortgage products of $69.6 million in the first quarter represents an increase of 75% over the first quarter 2016 and comprised 53% of total revenue. Notably, this quarter marks the first period where non-mortgage revenue exceeded that of mortgage, evidencing the continued momentum of our diversification strategy
  • Co issues upside guidance for Q2, sees Q2 revs of $133-137 mln vs. $126.05 mln Capital IQ Consensus Estimate. Adjusted EBITDA is anticipated to be in the range of $23.5 - $25.0 million, implying year-over-year growth of 41% - 50%.
  • Co issues upside guidancefor FY17, sees FY17 revs of $535-545 mln vs. $514.13 mln Capital IQ Consensus Estimate. Adjusted EBITDA is anticipated to be in the range of $95 - $99 million, up 36% - 42% over full-year 2016 and an increase from prior guidance of $93 - $97 million

>>> CLVS/MYGN : Myriad Genetics and Clovis Oncology Sign Agreement for Use of FD

Myriad Genetics and Clovis Oncology (CLVS) announce a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis’ PARP inhibitor, Rubraca; financial terms of the deal were not disclosed (18.46)
Under the agreement, Myriad will submit a supplementary premarket approval application under its existing PMA for BRACAnalysis CDx to include Rubraca. The Myriad sPMA submission will fulfill a post-approval regulatory commitment by Clovis Oncology to the FDA for Rubraca.